Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window

Details for Australian Patent Application No. 2004319797 (hide)

Owner H. Lundbeck A/S The Kenneth S. Warren Institute, Inc.

Inventors Cerami, Anthony; Coleman, Thomas; Brines, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004319797

Filing date 20 May 2004

Wipo publication date 12 January 2006

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

12 January 2006 Application Open to Public Inspection

  Published as AU-A-2004319797

12 January 2006 PCT application entered the National Phase

6 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

11 December 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Name H. Lundbeck A/S and The Kenneth S. Warren Institute, Inc., Application No. 2004319797, under INID (43), correct the date to 15 December 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004319799-Novel extended release composition of Venlafaxine hydrochloride containing polyvinyl acetate

2004319796-Method for thermographic lump separation of raw material (variants) and device for carrying out said method (variants)